Therapeutic targets and limits of minocycline neuroprotection in experimental ischemic stroke

BACKGROUND: Minocycline, a second-generation tetracycline with anti-inflammatory and anti-apoptotic properties, has been shown to promote therapeutic benefits in experimental stroke. However, equally compelling evidence demonstrates that the drug exerts variable and even detrimental effects in many...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Matsukawa, Noriyuki, Yasuhara, Takao, Hara, Koichi, Xu, Lin, Maki, Mina, Yu, Guolong, Kaneko, Yuji, Ojika, Kosei, Hess, David C, Borlongan, Cesar V
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2009
Teme:
Research Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2762982/
https://ncbi.nlm.nih.gov/pubmed/19807907
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2202-10-126
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items